Emma Allen-Vercoe
#178,346
Most Influential Person Now
British-Canadian molecular biologist
Emma Allen-Vercoe's AcademicInfluence.com Rankings
Emma Allen-Vercoebiology Degrees
Biology
#15002
World Rank
#18894
Historical Rank
Microbiology
#996
World Rank
#1105
Historical Rank
Molecular Biology
#2587
World Rank
#2628
Historical Rank
Download Badge
Biology
Emma Allen-Vercoe's Degrees
- Bachelors Microbiology University of Guelph
Why Is Emma Allen-Vercoe Influential?
(Suggest an Edit or Addition)According to Wikipedia, Emma Allen-Vercoe is a British-Canadian Molecular biologist who is a Professor and Canada Research Chair at the University of Guelph. Her research considers the gut microbiome and microbial therapeutics to treat Escherichia coli.
Emma Allen-Vercoe's Published Works
Published Works
- Structure, Function and Diversity of the Healthy Human Microbiome (2012) (8630)
- A framework for human microbiome research (2012) (2113)
- Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood (2007) (1971)
- Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. (2012) (1493)
- A Catalog of Reference Genomes from the Human Microbiome (2010) (683)
- Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut (2013) (664)
- Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health (2019) (513)
- Towards standards for human fecal sample processing in metagenomic studies (2017) (479)
- Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host (2011) (423)
- Comparison of the Fecal Microbiota of Healthy Horses and Horses with Colitis by High Throughput Sequencing of the V3-V5 Region of the 16S rRNA Gene (2012) (293)
- Co-occurrence of anaerobic bacteria in colorectal carcinomas (2013) (271)
- Fecal microbiota transplantation: in perspective (2016) (245)
- Stability and biological activity of wild blueberry (Vaccinium angustifolium) polyphenols during simulated in vitro gastrointestinal digestion. (2014) (226)
- Fimbriae- and flagella-mediated association with and invasion of cultured epithelial cells by Salmonella enteritidis. (1999) (190)
- Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing (2012) (175)
- Fusobacterium nucleatum (2011) (143)
- The role of flagella, but not fimbriae, in the adherence of Salmonella enterica serotype Enteritidis to chick gut explant. (1999) (142)
- Evaluation of microbial community reproducibility, stability and composition in a human distal gut chemostat model. (2013) (133)
- Impact of food grade and nano-TiO2 particles on a human intestinal community. (2017) (123)
- Microbial ecosystems therapeutics: a new paradigm in medicine? (2013) (117)
- Changes in the equine fecal microbiota associated with the use of systemic antimicrobial drugs (2015) (112)
- Fusobacterium nucleatum Infection of Colonic Cells Stimulates MUC2 Mucin and Tumor Necrosis Factor Alpha (2011) (111)
- A review of the associations between single nucleotide polymorphisms in taste receptors, eating behaviors, and health (2018) (105)
- Fusobacterium and Enterobacteriaceae: important players for CRC? (2014) (103)
- Metabolic products of the intestinal microbiome and extremes of atherosclerosis. (2018) (91)
- Evolution of Invasion in a Diverse Set of Fusobacterium Species (2014) (78)
- Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. 1976. (2012) (77)
- Virulence of Salmonella enterica serotype Enteritidis aflagellate and afimbriate mutants in a day-old chick model (1999) (77)
- Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse Model (2015) (73)
- A Canadian Working Group report on fecal microbial therapy: microbial ecosystems therapeutics. (2012) (73)
- Development of the faecal microbiota in foals. (2016) (70)
- Approaches to studying and manipulating the enteric microbiome to improve autism symptoms (2015) (65)
- Metabolomic analysis of human fecal microbiota: a comparison of feces-derived communities and defined mixed communities. (2015) (63)
- Lack of flagella disadvantages Salmonella enterica serovar Enteritidis during the early stages of infection in the rat. (2003) (62)
- Colonisation of the chicken caecum by afimbriate and aflagellate derivatives of Salmonella enterica serotype Enteritidis. (1999) (60)
- SEF17 fimbriae are essential for the convoluted colonial morphology of Salmonella enteritidis. (1997) (58)
- Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity (2016) (58)
- Phenotypic and genotypic analyses of clinical Fusobacterium nucleatum and Fusobacterium periodonticum isolates from the human gut. (2008) (57)
- Bringing the gut microbiota into focus through microbial culture: recent progress and future perspective. (2013) (57)
- A collection of bacterial isolates from the pig intestine reveals functional and taxonomic diversity (2020) (57)
- Nanosilver-Mediated Change in Human Intestinal Microbiota (2014) (56)
- A vaccine and diagnostic target for Clostridium bolteae, an autism-associated bacterium. (2013) (51)
- The human gut microbiota with reference to autism spectrum disorder: considering the whole as more than a sum of its parts (2015) (50)
- Antivirulence Activity of the Human Gut Metabolome (2014) (46)
- Simulating distal gut mucosal and luminal communities using packed-column biofilm reactors and an in vitro chemostat model. (2015) (42)
- Considerations for best practices in studies of fiber or other dietary components and the intestinal microbiome. (2018) (41)
- Association of HLA-dependent islet autoimmunity with systemic antibody responses to intestinal commensal bacteria in children (2019) (40)
- Microbial Interactions and Interventions in Colorectal Cancer. (2017) (39)
- Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications. (2019) (38)
- The Human Gut Microbial Metabolome Modulates Fungal Growth via the TOR Signaling Pathway (2017) (38)
- Enteropathogenic Escherichia coli Tir translocation and pedestal formation requires membrane cholesterol in the absence of bundle‐forming pili (2006) (37)
- Administration of defined microbiota is protective in a murine Salmonella infection model (2015) (36)
- Mediterranean Diet Score: Associations with Metabolic Products of the Intestinal Microbiome, Carotid Plaque Burden, and Renal Function (2018) (35)
- Adhesion of Salmonella enterica var Enteritidis strains lacking fimbriae and flagella to rat ileal explants cultured at the air interface or submerged in tissue culture medium. (2000) (34)
- Metagenomics-Based, Strain-Level Analysis of Escherichia coli From a Time-Series of Microbiome Samples From a Crohn's Disease Patient (2018) (34)
- Amino Acid Residues within Enterohemorrhagic Escherichia coli O157:H7 Tir Involved in Phosphorylation, α-Actinin Recruitment, and Nck-Independent Pedestal Formation (2006) (33)
- Distribution, gene sequence and expression in vivo of the plasmid encoded fimbrial antigen of Salmonella serotype Enteritidis (1996) (33)
- Protease-Mediated Suppression of DRG Neuron Excitability by Commensal Bacteria (2017) (32)
- Selection of novel TB vaccine candidates and their evaluation as DNA vaccines against aerosol challenge. (2006) (31)
- Salmonella enterica var Typhimurium and Salmonella enterica var Enteritidis express type 1 fimbriae in the rat in vivo. (1997) (31)
- A Genomic Toolkit for the Mechanistic Dissection of Intractable Human Gut Bacteria. (2020) (30)
- Guelph Family Health Study: pilot study of a home-based obesity prevention intervention (2018) (29)
- Colonizing the embryonic zebrafish gut with anaerobic bacteria derived from the human gastrointestinal tract. (2013) (28)
- Avian‐ and mammalian‐derived antibodies against adherence‐associated proteins inhibit host cell colonization by Escherichia coli O157:H7 (2007) (27)
- Using bioreactors to study the effects of drugs on the human microbiota. (2018) (26)
- Expression of type 1 fimbriae (SEF 21) of Salmonella enterica serotype enteritidis in the early colonisation of the rat intestine. (2001) (26)
- The effect of a microbial ecosystem therapeutic (MET-2) on recurrent Clostridioides difficile infection: a phase 1, open-label, single-group trial. (2021) (26)
- The variant rpoS allele of S. enteritidis strain 27655R does not affect virulence in a chick model nor constitutive curliation but does generate a cold-sensitive phenotype. (1998) (25)
- Optimization of metabolomics of defined in vitro gut microbial ecosystems. (2016) (25)
- Microbial composition analysis of Clostridium difficile infections in an ulcerative colitis patient treated with multiple fecal microbiota transplantations. (2014) (25)
- Expression of SEF17 fimbriae by Salmonella enteritidis (1997) (23)
- Drivers of human gut microbial community assembly: coadaptation, determinism and stochasticity (2018) (21)
- Intestinal microbiota as a tetrahydrobiopterin exogenous source in hph-1 mice (2017) (20)
- A carboxy-terminal domain of Tir from enterohemorrhagic Escherichia coli O157:H7 (EHEC O157:H7) required for efficient type III secretion. (2005) (20)
- Invasions of Host-Associated Microbiome Networks (2017) (20)
- A human gut ecosystem protects against C. difficile disease by targeting TcdA (2017) (20)
- An efficient system for markerless gene replacement applicable in a wide variety of enterobacterial species. (2007) (20)
- Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile (2019) (17)
- A chemical and biological toolbox for Type Vd secretion: Characterization of the phospholipase A1 autotransporter FplA from Fusobacterium nucleatum (2017) (17)
- Rebooting the microbiome (2016) (16)
- Artificial stool transplantation: progress towards a safer, more effective and acceptable alternative (2013) (16)
- Illuminating the microbiome’s dark matter: a functional genomic toolkit for the study of human gut Actinobacteria (2018) (15)
- A survey of Fusobacterium nucleatum genes modulated by host cell infection (2019) (13)
- Circadian influence on the microbiome improves heart failure outcomes. (2020) (13)
- Gut microbial biofilm composition and organisation holds the key to CRC (2019) (13)
- Effects of Antibiotic Pretreatment of an Ulcerative Colitis-Derived Fecal Microbial Community on the Integration of Therapeutic Bacteria In Vitro (2020) (12)
- Function is what counts: how microbial community complexity affects species, proteome and pathway coverage in metaproteomics (2020) (12)
- Protease‐dependent excitation of nodose ganglion neurons by commensal gut bacteria (2020) (11)
- Complete genome sequences and analysis of the Fusobacterium nucleatum subspecies animalis 7-1 bacteriophage ɸFunu1 and ɸFunu2. (2016) (10)
- Fusobacterium varium in Ulcerative Colitis: Is It Population-Based? (2014) (10)
- Phylogenetic Clustering of Genes Reveals Shared Evolutionary Trajectories and Putative Gene Functions (2018) (10)
- Culturing Human Gut Microbiomes in the Laboratory. (2021) (9)
- Deteriorating microbiomes in agriculture - the unintended effects of pesticides on microbial life (2022) (8)
- A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice. (2020) (8)
- Interaction between a Broad-spectrum Antibiotic and Silver Nanoparticlesin a Human Gut Ecosystem (2016) (8)
- Comparative study of the in vitro fermentative characteristics of fenugreek gum, white bread and bread with fenugreek gum using human faecal microbes (2015) (8)
- Tracing incorporation of heavy water into proteins for species-specific metabolic activity in complex communities. (2020) (7)
- Rarimicrobium hominis gen. nov., sp. nov., representing the fifth genus in the phylum Synergistetes that includes human clinical isolates. (2015) (6)
- Modulation of the Host Cell Transcriptome and Epigenome by Fusobacterium nucleatum (2021) (6)
- The Human Microbiome Handbook (2016) (5)
- Quantitative proteomic profiling of shake-flask versus bioreactor growth reveals distinct responses of Agrobacterium tumefaciens for preparation in molecular pharming. (2020) (5)
- Metabonomic Evaluation of Fecal Water Preparation Methods: The Effects of Ultracentrifugation (2018) (5)
- Defined gut microbial communities: promising tools to understand and combat disease. (2021) (5)
- In vitro susceptibility of human gut microbes to potential food preservatives based on immobilized phenolic compounds (2022) (5)
- 1D 1H NMR as a Tool for Fecal Metabolomics (2020) (5)
- The microbiome: what it means for medicine. (2014) (4)
- Analysis of the fungal, archaeal and bacteriophage diversity in the human distal gut (2011) (4)
- Perspectives for Consideration in the Development of Microbial Cell Reference Materials (2019) (4)
- Corrigendum: Intestinal microbiota as a tetrahydrobiopterin exogenous source in hph-1 mice (2017) (4)
- Manipulating the gut microbiota (2020) (3)
- Bacteriophage-Mediated Perturbation of Defined Bacterial Communities in an In Vitro Model of the Human Gut (2022) (3)
- Using bugs as drugs: Microbial ecosystem therapeutics. (2015) (3)
- Fusobacteria: physiology, form, and function (2020) (3)
- Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health (2019) (2)
- Bioactive small molecules produced by the human gut microbiome modulate Vibrio cholerae sessile and planktonic lifestyles (2021) (2)
- A154 DIRECT BACTERICIDAL EFFECT OF PANTOPRAZOLE ON BACTERIAL ISOLATES FROM THE GUT MICROBIOME (2019) (1)
- Data on the gut and saliva microbiota from a cohort of atherosclerosis patients determined by 16S rRNA gene sequencing (2018) (1)
- FplA From Fusobacterium nucleatum is a Type Vd autotransporter phospholipase with a proposed role in altered host signaling and evasion of autophagy (2017) (1)
- Tu1982 Investigating the Therapeutic Potential of Met-1 Probiotic Mixture in an Infectious vs. Chemically-Induced Model of Acute Colitis in Mice (2013) (1)
- Influence of free and immobilized chitosan on a defined human gut microbial ecosystem. (2022) (1)
- Co-occurrence of anaerobic bacteria in colorectal carcinomas (2013) (1)
- Prospective manipulation of the gut microbiome with Microbial Ecosystem Therapeutic 4 (MET4) in locoregionally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation (ROMA2). (2021) (1)
- Mo1669 A Human Gut Ecosystem Protects Against C. difficile Disease and Decreases Inflammation by Targeting C. difficile Toxin tcdA (2016) (1)
- Corrigendum to "Effects of therapeutic hypothermia on the gut microbiota and metabolome of infants suffering hypoxic-ischemic encephalopathy at birth" [Int. J. Biochem. Cell Biol. 93 (December) (2017), 110-118]. (2019) (1)
- Expression of Campylobacter Jejuni flaA Epitopes within a Modified Salmonella Flagellin Expressed in Salmonella Enteritidis (1996) (1)
- Metabolically-targeted dCas9 expression in bacteria (2023) (1)
- Human microbiome and disease (2014) (1)
- Disentangling the microbial ecological factors impacting honey bee susceptibility to Paenibacillus larvae infection. (2022) (1)
- Editors’ Prelude to Microbiome Research Reports (2021) (0)
- The role of fimbriae and flagella in the pathogenesis of Salmonella enteritidis phage-type 4 infections. (1999) (0)
- First-in-class Microbial Ecosystem Therapeutic 4 (MET4) in combination with immune checkpoint inhibitors in patients with advanced solid tumors (MET4-IO Trial). (2023) (0)
- Referee acknowledgement for 2020 (2021) (0)
- Abstract 3050: Quality control samples for future population-based microbiome studies (2023) (0)
- Corrigendum to Tracing incorporation of heavy water into proteins for species-specific metabolic activity in complex communities. (2020) (0)
- The Robogut: A Bioreactor Model of the Human Colon for Evaluation of Gut Microbial Community Ecology and Function (2023) (0)
- Anaerobe and anaerobes: New developments (the viewpoints of the new Editors-in-Chief). (2023) (0)
- 81 Transplantation of Dysbiotic Microbiota Derived From UC Patients Promotes a Pro-Inflammatory Phenotype and Increased Susceptibility of Gnotobiotic Mice to Colitis (2014) (0)
- The influence of a probiotic/prebiotic supplement on microbial and metabolic parameters of equine cecal fluid or fecal slurry in vitro. (2023) (0)
- Enterohemorrhagic Escherichia coli responds to gut microbiota metabolites by altering metabolism and activating stress responses (2023) (0)
- The next generation of probiotics: Microbial ecosystem therapeutics (2017) (0)
- Protease-mediated effects of commensal bacteria on nociceptive dorsal root ganglia neurons (2016) (0)
- Abstract WP404: Intestinal Microbiome and Carotid Atherosclerosis (2018) (0)
- Invasion by Fusobacterium nucleatum Causes Upregulation of dll4 and klf4 Expression in Caco2 Cells (2020) (0)
- 39 EFFECT OF MICROBIAL ECOSYSTEM THERAPEUTICS (MET-2) ON RECURRENT CLOSTRIOIDES DIFFICILE INFECTION: AN OPEN-LABEL, SINGLE-GROUP PRELIMINARY STUDY (2020) (0)
- Bacterial lipopolysaccharide modulates immune response in the colorectal tumor microenvironment (2022) (0)
- Anaerobes in the microbiome. (2021) (0)
- Bacterial Invasion of Host Cells: Stealth warfare: The interactions of EPEC and EHEC with host cells (2004) (0)
- Role for platelet toll-like receptor 4 (TLR4) in the formation of Neutrophil Extracellular Traps (NETs) in sepsis (44.22) (2007) (0)
- Dietary nitrate and corresponding gut microbiota prevent cardiac dysfunction in obese mice. (2023) (0)
- Use of an ileal explant model to study the contribution of S. enteritidis fimbrial lectins to infection in the rat gut (1999) (0)
- Impact of food preservatives based on immobilized phenolic compounds on an in vitro model of human gut microbiota. (2022) (0)
- Commensals make the most of their hosts. (2021) (0)
- Gut bacteria linked to Inflammatory Bowel Disease (2012) (0)
- Characterizing prophages in the genus Fusobacterium. (2023) (0)
- Alterations in intestinal Proteobacteria and antimicrobial resistance gene burden in individuals administered microbial ecosystem therapeutic (MET-2) for recurrent Clostridioides difficile infection (2022) (0)
- A Comparison of Methods to Maintain the Equine Cecal Microbial Environment In Vitro Utilizing Cecal and Fecal Material (2022) (0)
- Structure and synthesis of a vaccine and diagnostic target for Enterocloster bolteae, an autism-associated gut pathogen - Part II. (2023) (0)
- Acknowledgment of Ad Hoc Reviewers (2016) (0)
- A283 SECRETIONS OF INTESTINAL MICROBIOTA INCREASE THE EXCITABILITY OF VAGAL AFFERENT NEURONS VIA A PROTEASE ACTIVATED RECEPTOR 2 (PAR2)-DEPENDENT PATHWAY. (2018) (0)
- Su1749 Minimalist Defined Gut Microbial Ecosystem Demonstrates Protection Against Clostridium difficile Toxin-Mediated Effects In Vitro via Toxin Degradation (2016) (0)
- Stool substitute transplant therapy for the eradication of Clostridium difficile infection: ‘RePOOPulating’ the gut (2013) (0)
- 7 The use of in vitro fermentation methods to simulate an equine cecal environment (2021) (0)
- S-32-02 Characterization and toxicology of azo dye metabolites (2022) (0)
- Effects of defined gut microbial ecosystem components on virulence determinants of Clostridioides difficile (2019) (0)
This paper list is powered by the following services:
Other Resources About Emma Allen-Vercoe
What Schools Are Affiliated With Emma Allen-Vercoe?
Emma Allen-Vercoe is affiliated with the following schools: